Cargando…

Efficacy and safety of individually tailored antiplatelet therapy in patients with acute coronary syndrome after coronary stenting: a single center, randomized, feasibility study

BACKGROUND: Low responsiveness to clopidogrel (LRC) is associated with increased risk of ischemic events. This study was aimed to explore the feasibility of tailored antiplatelet therapy according to the responsiveness to clopidogrel. METHODS: A total of 305 clopidogrel naïve patients with acute cor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Hong-Chang, Li, Yi, Guan, Shao-Yi, Li, Jing, Wang, Xiao-Zeng, Jing, Quan-Min, Wang, Zu-Lu, Han, Ya-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308455/ https://www.ncbi.nlm.nih.gov/pubmed/25678901 http://dx.doi.org/10.11909/j.issn.1671-5411.2015.01.003

Ejemplares similares

Clinical Presentations, Antiplatelet Strategies and Prognosis of Patients with Stent Thrombosis: An Observational Study of 140 Patients
por: Han, Ya-Ling, et al.
Publicado: (2012)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015)

Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review
por: Carciotto, Gabriele, et al.
Publicado: (2023)

Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
por: Kao, Chih-Chin, et al.
Publicado: (2021)

Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice
por: Cho, Min Soo, et al.
Publicado: (2017)

Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
por: Luo, Lin, et al.
Publicado: (2022)

Antiplatelet therapy in patients with coronary artery stents for noncardiac surgery: Role of thromboelastography
por: Jain, Rashmi, et al.
Publicado: (2011)

Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis
por: Yin, Shang-He-Lin, et al.
Publicado: (2019)

Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis
por: Xu, Yi, et al.
Publicado: (2021)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
por: Han, Jialun, et al.
Publicado: (2023)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
por: Shen, Ying, et al.
Publicado: (2015)

Trends in antiplatelet strategies 12-months following coronary stent placement in anticoagulated patients
por: Gamvroulas, Eleni M., et al.
Publicado: (2023)

Analysis of individualized antiplatelet therapy for patients of acute coronary syndrome after percutaneous coronary intervention under the guidance of platelet function: A one-center retrospective cohort study
por: Dang, Wenxi, et al.
Publicado: (2021)

Genotype- and Phenotype-Directed Personalization of Antiplatelet Treatment in Patients with Non-ST Elevation Acute Coronary Syndromes Undergoing Coronary Stenting
por: Ahn, Sung Gyun, et al.
Publicado: (2013)

Long-term follow-up study of elderly patients with covered stent implantation after coronary perforation
por: Wang, Geng, et al.
Publicado: (2014)

Safety and Feasibility of Coronary Stenting in Unprotected Left Main Coronary Artery Disease in the Real World Clinical Practice—A Single Center Experience
por: Lee, Wei-Chieh, et al.
Publicado: (2014)

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Hu, Mengjin, et al.
Publicado: (2022)

Antiplatelet Therapy and Percutaneous Coronary Interventions
por: Davanzo, Rene Hameau, et al.
Publicado: (2021)

Feasibility of Quantitative Flow Ratio Virtual Stenting for Guidance of Serial Coronary Lesions Intervention
por: Guan, Shaofeng, et al.
Publicado: (2022)

Impact of prior coronary stenting on the outcome of subsequent coronary artery bypass grafting
por: Cheng, Yu-Ting, et al.
Publicado: (2017)

Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents
por: Wang, Huili, et al.
Publicado: (2015)

Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis
por: Geng, Xue, et al.
Publicado: (2020)

Editorial: The individualization of antiplatelet therapy in coronary artery disease: escalation or de-escalations
por: Lee, Sang Yeub, et al.
Publicado: (2023)

Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study
por: Zhang, Juan, et al.
Publicado: (2022)

The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients
por: Fan, Zhong-Guo, et al.
Publicado: (2016)

Dual Antiplatelet Therapy Over 6 Months Increases the Risk of Bleeding after Biodegradable Polymer-Coated Sirolimus Eluting Stents Implantation: Insights from the CREATE Study
por: ZHANG, LEI, et al.
Publicado: (2014)

Coronary collateral circulation: Effects on outcomes of acute anterior myocardial infarction after primary percutaneous coronary intervention
por: Wang, Bin, et al.
Publicado: (2011)

Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long‐Term Outcomes
por: Kinlay, Scott, et al.
Publicado: (2021)

Adherence to dual antiplatelet therapy after coronary stenting: A study conducted at two Vietnamese hospitals
por: Tien Hoang, Anh, et al.
Publicado: (2021)

Intensity of antiplatelet therapy and percutaneous coronary intervention
por: Aronow, Wilbert S
Publicado: (2009)

Dual Antiplatelet Therapy in Coronary Artery Disease
por: Sharma, Raghav, et al.
Publicado: (2020)

Risk Factors for Coronary Drug-Eluting Stent Thrombosis: Influence of Procedural, Patient, Lesion, and Stent Related Factors and Dual Antiplatelet Therapy
por: Sudhir, Krishnankutty, et al.
Publicado: (2013)

Safety and Necessity of Antiplatelet Therapy on Patients Underwent Endovascular Aortic Repair with Both Stanford Type B Aortic Dissection and Coronary Heart Disease
por: He, Rui-Xia, et al.
Publicado: (2017)

CYP2C19 genotype has prognostic value in specific populations following coronary stenting
por: Wang, Wenyao, et al.
Publicado: (2021)

Clinical outcomes of prolonged dual antiplatelet therapy after coronary drug-eluting stent implantation in dialysis patients
por: Park, Seokwoo, et al.
Publicado: (2020)

A case report of atraumatic splenic rupture after coronary stenting and dual antiplatelet therapy: Causality or relationship?
por: Boccanelli, Paolo, et al.
Publicado: (2021)

A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Li, Yachao, et al.
Publicado: (2023)

Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis
por: Liu, Liyao, et al.
Publicado: (2018)

Duration of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Treated With New Generation Stents: A Meta-Analysis of Randomized Controlled Trials
por: Zhang, Wen-Jiao, et al.
Publicado: (2021)

Successful opening in-stent chronic total occlusion lesion of coronary artery by excimer laser coronary angioplasty
por: Bai, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hsjt3ajhsk66ceqdelkehi76fo